
Hemoglobinopathies Market Sees Growth with Gene Therapy Diagnostics & Drug Advancements Through 2031| DataM Intelligence
The hemoglobinopathies market is advancing rapidly, driven by gene therapy, new drugs, and rising access for treating sickle cell disease and thalassemia. NEW YORK, NY, UNITED STATES, June 30, 2025 /EINPresswire.com/ -- The Hemoglobinopathies …